Define the Reimbursement Scope and Strategic Intent
The founder articulates why a health economics and reimbursement strategy is required at this precise stage of venture maturity. They define whether the objective is to secure NHS tariff coding, unlock private medical insurance coverage, or establish a direct business-to-business healthcare procurement route.
Establishing a clear scope prevents wasting resources on irrelevant clinical or economic modelling for non-viable buyer segments. It ensures the venture focuses exclusively on the commercialisation pathway that matches its target clinical deployment and buyer profile, maximising speed to market.
A documented scope charter outlining the target payment ecosystem, decision-maker personas, and the precise economic milestone required. The founder must explicitly state the core hypothesis regarding who pays, how much, and through which exact budget code or procurement mechanism.
Five questions an expert would ask when reviewing your output
Use these to challenge assumptions, pressure-test your logic, and check the quality of this action's output in the context of the parent task and wider venture development.
- 1
What specific clinical pathway trigger or commercial milestone makes addressing reimbursement urgent right now?
- 2
Why have you chosen this specific payment mechanism over alternative commissioning pathways in your target health system?
- 3
How does this reimbursement objective align with your current clinical evidence generation plan?
- 4
What evidence do you have that the target buyer actually utilises the payment code you intend to target?
- 5
If this specific reimbursement route fails, what is the immediate secondary commercial fallback?